Guidelines for the diagnosis and management of osteoporosis in Poland :  Update 2017

Lorenc, Roman; Głuszko, Piotr; Franek, Edward; Jabłoński, Mirosław; Jaworski, Maciej; Kalinka, Ewa; Karczmarewicz, Elżbieta; Kostka, Tomasz; Księżopolska-Orłowska, Krystyna; Marcinowska-Suchowierska, Ewa; Misiorowski, Waldemar; Wiȩcek, Andrzej

doi:10.5603/ep.2017.0062

Cited by 38 publications

(43 citation statements)

References 7 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In untreated women major and hip fractures probability increased therapy by Camacho et al [2]. After some discussion and with the awareness of limitations of FRAX [3,4], the same thresholds were proposed in Poland by Lorenc et al [5], and they remain valid [6]. One may expect that baseline fracture probability in efficiently treated patients should diminish or stabilise at follow-up.…”

Section: Resultsmentioning

confidence: 99%

The efficacy of pharmacotherapy in postmenopausal osteoporosis: a longitudinal observational study

Pluskiewicz

Adamczyk

Franek

et al. 2019

Endokrynologia Polska

Self Cite

View full text Add to dashboard Cite

Introduction: The aim of the study was an assessment of longitudinal changes in fracture probability in postmenopausal women. Material and methods: A group of 226 postmenopausal women at baseline mean age 66.46 ± 7.96 years were studied. There were 21 women without therapy, 102 taking calcium + vitamin D, and 103 women on antiresorptive therapy, in the study group. Data concerning clinical risk factors for osteoporosis and hip BMD were gathered. Fracture probability for major and hip fractures was established using FRAX TM. Results: Mean follow-up time was 2.43 ± 0.59 years. Baseline FRAX value in the whole group for major fracture was 7.1 ± 4.18, and at follow-up it was 7.44 ± 4.04. Respective results for FRAX for hip fracture were 3.17 ± 2.69 and 3.02 ± 2.35. In the whole group the probability for major fractures significantly increased during follow-up (p < 0.05) and for hip fracture did not change. In non-treated patients and patients taking calcium + vitamin D the fracture probability increased significantly. In patients on antiresorptive therapy the fracture probability did not change, which was connected with an improvement in bone status assessed by DXA. Femoral neck T-score in the whole group did not change, in those not treated and taking calcium + vitamin D it decreased significantly (p < 0.05), while in treated women it increased significantly (p < 0.05). In patients with improved bone status the FRAX values for major and hip fractures decreased by 0.44 ± 1.62 and 0.36 ± 1.19, respectively. Conversely, in patients with worsening T-score value the FRAX values increased by 1.33 ± 1.42 and 0.66 ± 1.25, respectively. Conclusion: Antiresorptive therapy stabilises fracture probability in postmenopausal women due to improvement in bone status.

show abstract

Section: Resultsmentioning

confidence: 99%

The efficacy of pharmacotherapy in postmenopausal osteoporosis: a longitudinal observational study

Pluskiewicz

Adamczyk

Franek

et al. 2019

Endokrynologia Polska

Self Cite

View full text Add to dashboard Cite

show abstract

“…Regular physical exercise (also resistance training) is recommended for seniors even over the age of 80-85. The benefits of strength training include health-promoting changes in the musculoskeletal system, which include slower development of sarcopenia, the prevention of osteoporosis, fractures and falls, and increased (functional) mobility to facilitate daily activities [34]. Research by Marchewka and colleagues demonstrated that the level of PA in the developmental period of life (before the age of 35) has a positive effect on the quality of life in the old age [35].…”

Section: Physioprophylaxis Through Pa Among the Elderlymentioning

confidence: 99%

“…Table 1. Primary and secondary physioprophylaxis in physiotherapy through PA (an original approach) [15,16,33,34,37,46,47,48,49].…”

Section: Our Original Approach To Physioprophylaxismentioning

confidence: 99%

Physical Activity in Primary and Secondary Physioprophylaxis

Kubińska¹,

Zaworski²,

Mysula³

et al. 2020

hpc

View full text Add to dashboard Cite

Authors' contribution Wkład autorów: A. Study design/planning zaplanowanie badań B. Data collection/entry zebranie danych C. Data analysis/statistics dane-analiza i statystyki D. Data interpretation interpretacja danych E. Preparation of manuscript przygotowanie artykułu F. Literature analysis/search wyszukiwanie i analiza literatury G. Funds collection zebranie funduszy Summary Physioprophylaxis is a physiotherapeutic procedure consisting in counteracting, slowing down, inhibiting or removing adverse effects associated with an incorrect lifestyle, involutionary changes and disease processes. Physical activity (PA), health education, reduction of risk factors, and functional diagnostics are used to implement these goals. Physioprophylaxis makes it possible to avoid or stop the development of functional problems or disorders. It enables the prevention of civilization diseases, aging processes and disability by performing professional and daily activities ergonomically. Physioprophylaxis introduces PA and behaviors that strengthen the factors influencing health protection by preventing health threats. The lack of theoretical studies devoted to physioprophylaxis highlights the need to examine this topic. The purpose of this article is to describe an exemplary description (the author's) of primary and secondary physioprophylaxis using PA as an integral component of physical therapy, including its tasks. Primary physioprophylaxis strives to prevent the occurrence of diseases, and is directed towards healthy people. Secondary physioprophylaxis involves patients and is a selective process that prevents the recurrence of the disease being treated and also reduces other risks to health. Physioprophylaxis focusing on health threats in healthy people has been scientifically demonstrated to maintain and strengthen the current physiological and functional state. It is also a way to minimize the scope of adverse disorders associated with diseases for people with medical conditions achieved using PA.

show abstract

“…Osteoporosis is the most common bone disease in humans, especially Caucasians, women, and older people, which is characterized by low BMD, deterioration of bone tissue, and disruption of bone microarchitecture, 6 , 16 leading to an increase in the risk of fractures. Recently, osteoporosis is increasingly becoming a global epidemic with the increasing aging population.…”

Section: Introductionmentioning

confidence: 99%

Bone mineral density in patients with chronic heart failure: a meta-analysis

Xing¹,

Lv²,

Gao³

et al. 2018

CIA

View full text Add to dashboard Cite

ObjectiveThis study aimed to verify the existing relationship between bone mineral density (BMD) and chronic heart failure (CHF) by meta-analysis.MethodsDatabases, including PubMed, Web of Science, and Chinese National Knowledge Infrastructure, published in English or Chinese up to February 28, 2017, were searched for studies on the association between CHF and BMD. Two independent reviewers collected the relevant articles. The standard mean deviation (SMD) and 95% confidence interval were calculated for BMD with fixed- and random-effect models. Subgroup and sensitivity analyses were also conducted.ResultsA total of six studies (552 CHF and 243 non-CHF patients) were included. The results indicated that the patients with CHF had a lower total BMD compared with the non-CHF patients. Similar effects were also observed for femoral neck, arm, leg, and trunk BMD. However, no difference was observed in the lumbar spine BMD. The SMD of total BMD in New York Heart Association classes I or II (NYHA I or II) patients was −0.62, while that in NYHA III or IV patients was −0.87, and the SMD of femoral bone mineral density in NYHA I or II patients was −0.47, while that in NYHA III or IV patients was −1.07. Moreover, vitamin D and parathyroid hormone (PTH) were also found to be associated with CHF.ConclusionPatients with CHF had a lower total BMD and femoral neck, arm, leg, or trochanter BMD than patients with non-CHF. Vitamin D reduced, whereas PTH increased, with the severity of CHF. The clinical significance of the present findings remains uncertain and should be confirmed by future studies.

show abstract

Guidelines for the diagnosis and management of osteoporosis in Poland : Update 2017

Cited by 38 publications

References 7 publications

The efficacy of pharmacotherapy in postmenopausal osteoporosis: a longitudinal observational study

The efficacy of pharmacotherapy in postmenopausal osteoporosis: a longitudinal observational study

Physical Activity in Primary and Secondary Physioprophylaxis

Bone mineral density in patients with chronic heart failure: a meta-analysis

Contact Info

Product

Resources

About